K‐ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos
暂无分享,去创建一个
M. Ridanpää | S. Anttila | K. Husgafvel‐Pursiainen | H. Vainio | T. Partanen | A. Karjalainen | P. Hackman | L. Heikkilä | O. Taikina-aho
[1] S. Anttila,et al. Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutations. , 1993, Environmental health perspectives.
[2] S. Anttila,et al. Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. , 1993, American journal of industrial medicine.
[3] H. Vainio. Mechanisms of Carcinogenesis in Risk Identification , 1992 .
[4] H. Bartsch,et al. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. , 1992, Cancer research.
[5] R. Metcalf,et al. p53 and Kirsten-ras mutations in human mesothelioma cell lines. , 1992, Cancer research.
[6] K. Hemminki,et al. Serum oncoproteins and growth factors in asbestosis and silicosis patients , 1992, International journal of cancer.
[7] R. Metcalf,et al. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners , 1992, The Lancet.
[8] R. Ueda,et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. , 1992, Cancer research.
[9] Thierry Soussi,et al. TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.
[10] J. Lasky,et al. The Pathobiology of Asbestos‐Induced Lung Disease: A Proposed Role for Macrophage‐Derived Growth Factors , 1991, Annals of the New York Academy of Sciences.
[11] T. Lee,et al. Role of Peptide Growth Factors in Asbestos‐Related Human Lung Cancer , 1991, Annals of the New York Academy of Sciences.
[12] S. Jhanwar,et al. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. , 1991, Cancer research.
[13] J. Minna,et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.
[14] S. Rodenhuis,et al. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. , 1991, Journal of the National Cancer Institute.
[15] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[16] R. Pero,et al. Activated protooncogenes in human lung tumors from smokers. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Rodenhuis,et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.
[18] M. Barbacid,et al. ras oncogenes: their role in neoplasia , 1990, European journal of clinical investigation.
[19] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[20] Marshall W. Anderson,et al. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Rodenhuis,et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.
[22] P. Vineis,et al. Estimates of the proportion of lung cancer attributable to occupational exposure. , 1988, Carcinogenesis.
[23] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[24] R. L. Carter,et al. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.
[25] E. C. Hammond,et al. MORTALITY EXPERIENCE OF INSULATION WORKERS IN THE UNITED STATES AND CANADA, 1943‐1976 * , 1979, Annals of the New York Academy of Sciences.
[26] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[27] J. Barrett,et al. Possible cellular and molecular mechanisms for asbestos carcinogenicity. , 1992, American journal of industrial medicine.
[28] J. Bos,et al. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. , 1986, Gene.
[29] Iarc Monographs,et al. Cumulative Index to IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. , 1986, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.
[30] J. Aisner,et al. Asbestos-related malignancy. , 1986, Critical reviews in oncology/hematology.